Given the involvement of Dyrk1A in severe and common neurological diseases, a number of efforts have been put into developing competitive small chemical inhibitors against Dyrk kinase activity, and several of such inhibitor compounds are currently available. This evidence concerns the gene DYRK1A and nervous system disorder.